Table 4:
Algorithm for multiple myeloma | Sensitivity (95% CI) | Specificity (95% CI) | PPV (95% CI) |
---|---|---|---|
Non-VA Algorithm 1 | 0.86 (0.83–0.88) | 0.57 (0.48–0.66) | 0.92 (0.90–0.94) |
Non-VA Algorithm 2 | 0.85 (0.82–0.88) | 0.57 (0.48–0.66) | 0.92 (0.90–0.94) |
VA Algorithm 1 | 0.28 (0.24–0.31) | 0.96 (0.91–0.99) | 0.98 (0.94–0.99) |
VA Algorithm 2 | 0.63 (0.60–0.67) | 0.71 (0.63–0.79) | 0.93 (0.90–0.95) |
VA Recommended Algorithm | 0.45 (0.41–0.49) | 0.94 (0.88–0.97) | 0.98 (0.95–0.99) |
Algorithm for initiation of treatment | Sensitivity (95% CI) | Specificity (95% CI) | PPV (95% CI) |
Non-VA Algorithm 1 | 0.92 (0.89–0.94) | 0.28 (0.22–0.35) | 0.77 (0.73–0.80) |
Non-VA Algorithm 2 | 0.92 (0.89–0.94) | 0.29 (0.23–0.36) | 0.77 (0.74–0.81) |
VA Algorithm 1 | 0.35 (0.31–0.40) | 0.93 (0.88–0.96) | 0.93 (0.88–0.96) |
VA Algorithm 2 | 0.74 (0.70–0.78) | 0.64 (0.57–0.71) | 0.85 (0.81–0.88) |
VA Recommended Algorithm | 0.58 (0.54–0.63) | 0.89 (0.84–0.93) | 0.93 (0.90–0.96) |
VA Recommended Algorithm includes selection criteria of VA Algorithm 1, but with the removal of height and weight restriction and the addition of requiring at least two billable visits in VA in the three years prior to initial treatment date (to define users of VA).
CI = Confidence Interval; PPV = Positive Predictive Value